Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

521 public trials 167 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Santo André, São Paulo, Brazil
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 49 locations
View Trial Details
Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

NCT06994845

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Prim Childrens Hosp Inv Pharm Salt Lake City, Utah, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 20 locations
View Trial Details
Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

NCT06989359

Conditions
Autoimmune Diseases, C3G, Complement-mediated Kidney Disease, +13 more
Locations
  • ADARx Clinical Site Doral, Florida, United States
  • ADARx Clinical Site Miami, Florida, United States
  • ADARx Clinical Site Pembroke Pines, Florida, United States
  • ADARx Clinical Site Iowa City, Iowa, United States
View all 38 locations
View Trial Details
Recruiting

Chinese Adults With Kidney Disease

NCT07522099

Conditions
Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations
  • ADARx Clinical Site Shenzhen, Guangdong, China
  • ADARx Clinical Site Guiyang, Guizhou, China
  • ADARx Clinical Site Zhengzhou, Henan, China
  • ADARx Clinical Site Baotou, Inner Mongolia, China
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

NCT02235857

Conditions
Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Nemours/A.I. duPont Hospital for Children Wilmington, Delaware, United States
  • Nemours Children's Health Orlando, Florida, United States
View Trial Details
Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

NCT04065438

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • Loma Linda University Hospital Loma Linda, California, United States
  • Nemours/Alfred I DuPont Hospital for Children Wilmington, Delaware, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details

Related conditions